A Meta-analysis of Intravenous Iron Therapy for Patients With Iron Deficiency and Heart Failure

Overview

Journal Am J Cardiol

Specialty Cardiology & Vascular Diseases

Date 2020 Dec 1

PMID 33259800

Citations 10

Authors

Mohammed Osman

Moinuddin Syed

Sudarshan Balla

Babikir Kheiri

Mohammed Faisaluddin

Christopher Bianco

Affiliations

Soon will be listed here.

Citing Articles

Iron deficiency in dogs suffering from atopic dermatitis.

Ramos C, Doulidis P, Polakova N, Burgener I, Jensen-Jarolim E, Cimarelli G BMC Vet Res. 2024; 20(1):506.

PMID: 39506866 PMC: 11539295. DOI: 10.1186/s12917-024-04350-y.

An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease.

Tumelty E, Chung I, Hussain S, Ali M, Addada H, Banerjee D Rev Cardiovasc Med. 2024; 25(4):144.

PMID: 39076544 PMC: 11264008. DOI: 10.31083/j.rcm2504144.

Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia.

Iolascon A, Andolfo I, Russo R, Sanchez M, Busti F, Swinkels D Hemasphere. 2024; 8(7):e108.

PMID: 39011129 PMC: 11247274. DOI: 10.1002/hem3.108.

Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials.

Mhanna M, Sauer M, Al-Abdouh A, Jabri A, Beran A, Barbarawi M Proc (Bayl Univ Med Cent). 2024; 37(3):466-476.

PMID: 38628339 PMC: 11018061. DOI: 10.1080/08998280.2024.2326387.

Cost-effective heart failure management: Meta-analysis of IV iron therapy in iron-deficient heart failure patients.

Myint P, Nandar P, Thet A, Orasanu G Am Heart J Plus. 2024; 22:100204.

PMID: 38558909 PMC: 10978398. DOI: 10.1016/j.ahjo.2022.100204.

References

Anker S, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H . Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009; 361(25):2436-48. DOI: 10.1056/NEJMoa0908355. View

Yancy C, Jessup M, Bozkurt B, Butler J, Casey Jr D, Colvin M . 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society.... J Card Fail. 2017; 23(8):628-651. DOI: 10.1016/j.cardfail.2017.04.014. View

Van Veldhuisen D, Ponikowski P, van der Meer P, Metra M, Bohm M, Doletsky A . Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency. Circulation. 2017; 136(15):1374-1383. PMC: 5642327. DOI: 10.1161/CIRCULATIONAHA.117.027497. View

Ponikowski P, Van Veldhuisen D, Comin-Colet J, Ertl G, Komajda M, Mareev V . Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur Heart J. 2014; 36(11):657-68. PMC: 4359359. DOI: 10.1093/eurheartj/ehu385. View

Ponikowski P, Kirwan B, Anker S, McDonagh T, Dorobantu M, Drozdz J . Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020; 396(10266):1895-1904. DOI: 10.1016/S0140-6736(20)32339-4. View